---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-001567"
form_type: "8-K"
ticker: "LMMY"
cik: "0001939937"
company_name: "Exousia Bio, Inc."
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:54:37.082047+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# LAMY appoints Stephen Townsend as COO; grants 250,000 shares as compensation

## Summary
- Stephen Townsend appointed as Chief Operating Officer, effective immediately, until March 2024 annual meeting.
- Compensation consists of 250,000 shares of LAMY common stock for 12 months of service.
- Townsend brings over 20 years of finance and real estate credit expertise to the role.

## SEC filing metadata
- accession: 0001683168-23-001567
- form_type: 8-K
- ticker: LMMY
- cik: 0001939937
- company_name: Exousia Bio, Inc.
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/0001683168-23-001567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/lamy_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-001567
- JSON: https://secwatch.observer/filing/0001683168-23-001567.json
- Plain text: https://secwatch.observer/filing/0001683168-23-001567.txt

## Key facts
- Executive change
  Stephen Edward Townsend was appointed as Chief Operating Officer at Exousia Bio, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On March 15, 2023, the board of directors (the “Board”) of LAMY (the “Company”) appointed Mr. Stephen Edward Townsend, to the Board as Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/0001683168-23-001567-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.